Newsroom | 5751 results

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Eyebot, the automated vision test kiosk that provides doctor-verified eyeglass prescriptions, today announced a strategic partnership with QUAY, the global eyewear brand known for on-trend design and premium materials at an attainable price point. Through the first-of-its-kind partnership, combining innovative technology with fashion, Eyebot's automated vision test kiosk is now available inside select QUAY retail stores, allowing customers to receive a d...

WATERTOWN, Mass.--(BUSINESS WIRE)--Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, today announced that it has been nominated for the Prix Galien USA and the inaugural Prix Galien Korea, both in the Best Startup category by The Galien Foundation. The Galien Foundation is the premier global institution recognizing and awarding outstanding achievements of innovators in life sciences. The dual recognition arrives alongside a defi...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 3:00 p.m. ET in Boston, MA. A live and archived webcast for these events, where applicable, will be available in the Investors...

BOSTON--(BUSINESS WIRE)--Ora, the world's leading ophthalmic contract research organization, appoints retina specialist Dr. John Trein as Therapeutic Lead, Posterior...

STUART, Fla.--(BUSINESS WIRE)--Stuart Therapeutics, Inc. (“Stuart”), a clinical-stage biopharmaceutical company developing first-in-class collagen-reparative therapeutics to treat eye diseases, today announced the appointment of David Jakeman as chief financial officer. Jakeman will lead the company's finance and accounting operations as Stuart advances its lead candidate, ST-100 for dry eye disease, through completion of its pending Phase 3b clinical trial and into preparations for commerciali...

WATERTOWN, Mass.--(BUSINESS WIRE)--Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced today that its shares have begun trading on the KOSDAQ market. The IPO marks a significant milestone as the company accelerates the development and global commercialization of its proprietary vascular stabilization pipeline. Founded in Boston in 2018, Ingenia is developing next-generation antibody therapeutics based on technologies ori...

CHICAGO--(BUSINESS WIRE)--Experiences That Matter Foundation received a $5,000 grant from the SBB Research Group Foundation, which awards monthly grants to support impactful organizations. Experiences That Matter Foundation, based in Chicago, Illinois, works to expand access to essential resources for communities that have historically been underserved. Guided by a commitment to equity and opportunity, the nonprofit helps close ongoing gaps in care for children and families who need support mos...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the second quarter ended July 3, 2026. Second Quarter 2026 Financial Overview Net sales of $93.5 million, up 111% Y/Y Net sales excluding China of $41.2 million, up 6.0% Y/Y China sales of $52.3 million up over 100%, 10% sequentially APAC sales up 189% Y/Y, ex-China sales up...

GAND, Belgio--(BUSINESS WIRE)--Azalea Vision, una healthtech belga, oggi ha annunciato che il co-fondatore e CTO Andrés Vasquez Quintero assumerà il ruolo di Chief Executive Officer con effetto immediato, e manterrà anche la carica di CTO. Questa transizione sottolinea la prossima pietra miliare dell'azienda, che punta a portare verso la fase dello sviluppo clinico la sua piattaforma di lenti a contatto intelligenti, dopo aver passato le selezioni per l'Acceleratore del Consiglio europeo per l'...

GHENT, Belgium--(BUSINESS WIRE)--Azalea Vision, a Belgian healthtech company, today announced that co-founder and CTO Andrés Vasquez Quintero will become Chief Executive Officer, effective immediately, while continuing as CTO. The transition marks the company’s next phase, advancing its smart contact lens platform into clinical development, following its selection for the European Innovation Council (EIC) Accelerator. As the inventor of Azalea Vision’s proprietary adaptive-optics platform, Vasq...